Percutaneous Electrolysis and Vacuum Myofascial Therapy deviceTrial.
Launched by UNIVERSITY OF CADIZ · Jan 27, 2021
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
Experimental group will be treated Therapeutic Percutaneous Electrolysis and Vacuum Myofascial Therapy device once week for four weeks associated with eccentric exercises devices at home and the control group will be included 10 sessions of ultrasound pulsatil therapy (US) and massage associated with eccentric exercises devices at home.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients of both sexes, aged between 18 and 60 years, in an active state of pain and with a diagnosis of one month of evolution.
- Exclusion Criteria:
- • Patients who are pregnant, have pacemakers and those surgically operated patients who have been treated with electrolysis and Vacuum Myofascial Therapy Device a month earlier
About University Of Cadiz
The University of Cádiz, an esteemed academic institution located in Spain, is dedicated to advancing medical research and clinical innovation through rigorous scientific inquiry. With a strong emphasis on interdisciplinary collaboration, the university fosters an environment that promotes the development of novel therapeutic strategies and enhances patient care. As a clinical trial sponsor, the University of Cádiz is committed to upholding the highest ethical standards and regulatory compliance, ensuring the safety and efficacy of its research initiatives while contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cadiz, Cádiz, Spain
Patients applied
Trial Officials
manuel Rodríguez Huguet, Physiotherapy
Principal Investigator
University of Cádiz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials